A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

NCT00884507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

389

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Placebo
DRUG: RO5313534
DRUG: RO5313534
DRUG: RO5313534

Sponsor

Hoffmann-La Roche